Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

6α,9α-Difluoroprednisolone 21-Butyrate

● In Stock

Catalogue No.:	VE008767
CAS No.:	N/A
Mol. Formula:	C25H32F2O6
Mol. Weight:	466.51 g/mol

Request a quote

Add to RFQ list

Additional information on 6α | 9α-Difluoroprednisolone 21-Butyrate

Parent drug

Prednisolone

IUPAC Name

2-((6S, 8S, 9R, 10S, 11S, 13S, 14S, 17R)-6, 9-difluoro-11, 17-dihydroxy-10, 13-dimethyl-3-oxo-6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl butyrate

Synonyms

N/A

Smiles

CCCC(OCC([C@@]1(O)CC[C@@]2([H])[C@]3([H])C[C@H](F)C4=CC(C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)=O)=O)=O

Description

6a,9a-Difluoroprednisolone 21-Butyrate is an impurity of Difluprednate which is a corticosteroid. It is chemically a butyrate ester of 6(alpha),9(alpha)-difluoro prednisolone acetate. It is sometimes abbreviated DFBA, for difluoroprednisolone butyrate acetate.

References

https://www.facebook.com/Drugscom. “FDA Approves Durezol.” Drugs.com, Drugs.com, 2022, www.drugs.com/newdrugs/sirion-therapeutics-announces-fda-approval-durezol-treatmentof-postoperative-ocular-inflammation-1031.html.